Interestingly, ARID1B1 and BRCA2 mutations were found to be SVZM+ tumor exclusive by deep NGS of the Heidelberg cohort as well as EPHA1, DECAF12L2, and ADCY5 by WES in the TCGA cohort. This evidence concerns the gene EPHA1 and neoplasm.